NCT05077215 2025-12-08Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial CancerEvergreen Therapeutics, Inc.Phase 3 Not yet recruiting450 enrolled
NCT05106127 2025-12-08Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus PemEvergreen Therapeutics, Inc.Phase 2 Not yet recruiting28 enrolled